Search Results - "Hatabu, Hiroto"

Refine Results
  1. 1

    Monitoring immune-checkpoint blockade: response evaluation and biomarker development by Nishino, Mizuki, Ramaiya, Nikhil H., Hatabu, Hiroto, Hodi, F. Stephen

    Published in Nature reviews. Clinical oncology (01-11-2017)
    “…Key Points A subset of patients receiving immune-checkpoint inhibitor therapy develop unconventional response patterns (termed 'pseudoprogression'), in which…”
    Get full text
    Journal Article
  2. 2

    Imaging of Cancer Immunotherapy: Current Approaches and Future Directions by Nishino, Mizuki, Hatabu, Hiroto, Hodi, F Stephen

    Published in Radiology (01-01-2019)
    “…Cancer immunotherapy using immune-checkpoint inhibitors has emerged as an effective treatment option for a variety of advanced cancers in the past decade…”
    Get full text
    Journal Article
  3. 3

    Interstitial Lung Abnormalities: State of the Art by Hata, Akinori, Schiebler, Mark L., Lynch, David A., Hatabu, Hiroto

    Published in Radiology (01-10-2021)
    “…The clinical importance of interstitial lung abnormality (ILA) is increasingly recognized. In July 2020, the Fleischner Society published a position paper…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy by Nishino, Mizuki, Sholl, Lynette M, Hatabu, Hiroto, Ramaiya, Nikhil H, Hodi, F. Stephen

    Published in The New England journal of medicine (16-07-2015)
    “…Among three patients with melanoma receiving anti–PD-1 antibodies, the use of checkpoint blockers led to the development of serious autoimmune pneumonitis, a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course by Nishino, Mizuki, Ramaiya, Nikhil H, Awad, Mark M, Sholl, Lynette M, Maattala, Jennifer A, Taibi, Myriam, Hatabu, Hiroto, Ott, Patrick A, Armand, Philippe F, Hodi, F Stephen

    Published in Clinical cancer research (15-12-2016)
    “…Investigate the clinical characteristics, radiographic patterns, and treatment course of PD-1 inhibitor-related pneumonitis in advanced cancer patients. Among…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    State of the art: Response assessment in lung cancer in the era of genomic medicine by Nishino, Mizuki, Hatabu, Hiroto, Johnson, Bruce E, McLoud, Theresa C

    Published in Radiology (01-04-2014)
    “…Tumor response assessment has been a foundation for advances in cancer therapy. Recent discoveries of effective targeted therapy for specific genomic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Imaging of Precision Therapy for Lung Cancer: Current State of the Art by Park, Hyesun, Sholl, Lynette M, Hatabu, Hiroto, Awad, Mark M, Nishino, Mizuki

    Published in Radiology (01-10-2019)
    “…Advances in characterization of molecular and genomic abnormalities specific to lung cancer have made precision therapy the current standard of care for lung…”
    Get full text
    Journal Article
  14. 14

    Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care by Nishino, Mizuki, Hatabu, Hiroto, Sholl, Lynette M, Ramaiya, Nikhil H

    Published in Radiographics (01-09-2017)
    “…Recent advances in understanding the molecular mechanisms of cancer have opened a new era of precision medicine for cancer treatment. Precision cancer…”
    Get full text
    Journal Article
  15. 15

    Expanding Applications of Pulmonary MRI in the Clinical Evaluation of Lung Disorders: Fleischner Society Position Paper by Hatabu, Hiroto, Ohno, Yoshiharu, Gefter, Warren B, Parraga, Grace, Madore, Bruno, Lee, Kyung Soo, Altes, Talissa A, Lynch, David A, Mayo, John R, Seo, Joon Beom, Wild, Jim M, van Beek, Edwin J R, Schiebler, Mark L, Kauczor, Hans-Ulrich

    Published in Radiology (01-11-2020)
    “…Pulmonary MRI provides structural and quantitative functional images of the lungs without ionizing radiation, but it has had limited clinical use due to low…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    The incidence of ALK inhibitor-related pneumonitis in advanced non-small-cell lung cancer patients: A systematic review and meta-analysis by Suh, Chong Hyun, Kim, Kyung Won, Pyo, Junhee, Hatabu, Hiroto, Nishino, Mizuki

    Published in Lung cancer (Amsterdam, Netherlands) (01-06-2019)
    “…•The overall incidence of ALK inhibitor pneumonitis was 2.14% in advanced NSCLC.•Patients from Japanese cohorts had a higher incidence of ALK-inhibitor…”
    Get full text
    Journal Article
  19. 19

    Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections by Miller, Ezra R, Putman, Rachel K, Vivero, Marina, Hung, Yin, Araki, Tetsuro, Nishino, Mizuki, Washko, George R, Rosas, Ivan O, Hatabu, Hiroto, Sholl, Lynette M, Hunninghake, Gary M

    “…[...]for five (15%) of these 26 patients (without a known clinical diagnosis of ILD), radiologic reports noted the presence of ILD and/or pulmonary fibrosis…”
    Get full text
    Journal Article
  20. 20

    Screening for lung cancer: Does MRI have a role? by Biederer, Juergen, MD, Ohno, Yoshiharu, MD, PhD, Hatabu, Hiroto, MD, Schiebler, Mark L., MD, van Beek, Edwin J.R., MD, Vogel-Claussen, Jens, MD, Kauczor, Hans-Ulrich, MD

    Published in European journal of radiology (01-01-2017)
    “…Highlights • From a technical point of view, the feasibility of using MRI for lung cancer screening is evident. • Experience with the clinical use of lung MRI…”
    Get full text
    Journal Article